Back to News & Events

Medisafe Finalist in Reuters Pharma Awards

Medisafe has been selected as a finalist in the Most Valuable Digital Therapy for Pharma category in the Reuters Pharma Awards 2022. Medisafe was selected among over 700 submissions due to its innovative approach to medication management and joins the ranks of other leading pharma organizations including Sanofi, Merck, Biogen, Takeda, and others in this prestigious award.

The final winners are set to be announced on December 1, 2022, in Philadelphia.

You may also like

Transforming Pharma Outcomes: Boosting Adherence & Persistence

Summary This case study examines the unmet needs in treatment adherence and persistence among patients with psoriasis, Crohn’s disease, and 

..Read More

There’s a Growing Confidence Among Pharma for 2025-26 Budgets

Pharmaceutical companies are increasingly leveraging digital solutions to drive patient engagement while simultaneously preparing for a transformative shift powered by 

..Read More

But What are Patients Thinking About Ai?

Artificial Intelligence (AI) is rapidly transforming healthcare, promising to enhance diagnosis accuracy, improve patient engagement, and streamline care delivery. Yet, 

..Read More

Want to Learn More?

We bring decades of experience to your challenges—and technology and solutions uniquely designed to meet your needs.

Contact Us